fpamed News

Video: Can Neuroscience help us eradicate psychopathy? Octavio Choi – TEDx Talk, Portland State University

Dr. Choi digs into the psychopaths brain, literally. He examines how their brain reacts and thinks compared to an average brain, hoping that we do our part to guide the psychopaths to a better life.

What Neuroscience Can and Cannot Answer | Journal of the American Academy of Psychiatry and the Law

We truly live in the golden age of neuroscience. Advances in technology over the past 20 years have given modern neuro-researchers tools of unprecedented power to probe the workings of the most complex machine in the universe (as far as we know).

HB Webinar: PTSD in Mass Tort & Multi-Plaintiff Litigation

Watch the FREE video recording of this webinar. Everything You Need to Know About Assessing PTSD Claims In Mass Tort Litigation: The “Team” Approach. Get up to speed on the medical and scientific aspects of PTSD in mass tort and multi-claimant cases. With Mark I. Levy, MD, DLFAPA and Sarah A. Hall, PhD.

PTSD Claims Brought by Facebook’s ‘Graphic Content’ Reviewers Goes to ADR, Putting Civil Action on Pause

Facebook can be great fun. How else would I have seen a video of an eight-year-old drummer-girl utterly thrashing Led Zeppelin’s Good Times Bad Times? Or a dog running away with a lit skyrocket as his human friends run, duck and ditch for their lives? Or what your cat looks like in a tuxedo?

Check out the upcoming HB Webinar

HB Webinar: The Opioid Addiction Story – What Tort Attorneys Should Know About Opiates & How This Epidemic Came to Be

As opioid addiction continues to claim lives and litigation continues to expand, attorneys who may have potential clients – as plaintiffs or defendants – will benefit from this 95-minute session with Dr. David Kan, who has been retained by plaintiffs in the opioid MDL in Ohio.

Mark I Levy Flopped

Mass Tort Litigation

The Team Approach to Forensic Psychiatric Assessment in Mass Tort or Multi-Plaintiff Complex Litigation There are key advantages to employing a “Single Team Approach” to assessing emotional damages claims in a mass tort population. Whether part of a class action, consolidated individual claims, multi-district litigation, or another procedure, a large population of claimants seeking emotional […]

Current Regulation of Mobile Mental Health Applications

James A. Armontrout, MD, John Torous, MD, Marsha Cohen, JD, Dale E. McNiel, PhD, and Renée Binder, MD — The Journal of the American Academy of Psychiatry and the Law — In recent years, the availability of software that is targeted toward the general public and designed to assist in the diagnosis and treatment of […]

Mark I Levy Flopped

“I Hurt but They Think I’m Faking!” What Are Somatic Symptom & Related Disorders & What Is Their Importance in Civil Litigation?

A passenger vehicle is rear-ended by a commercial vehicle traveling at 30 mph on a state road. The driver of the passenger vehicle is seat belted. The airbags deployed, and the vehicle suffered moderate rear end damage. Ambulance personnel note that the driver exited the vehicle without assistance, is awake, standing by the roadside and talking […]

6-13-18 NARTC Webinar – mTBI Claims in Litigation

Topics To Be Covered: 1. Asessing Emotional Disorders 1. Definitions – what is a TBI? – what makes a mild TBI “mild?” 2. 3-legged stool assessment: neurology, neuropsychology & psychiatry. 3. Neurology – Imaging Studies and Structural Assessment. • MRI. • DTI. • Tractography. 4. Problems with correlating imaging studies with mTBI studies. 5. Neuropsychology […]

mild Traumatic Brain Injury (mTBI) and Imaging Studies in Forensic Psychiatry

By Forensic Psychiatrist Mark I Levy, MD, DLFAPA Mild Traumatic Brain Injury (“mTBI” or “concussion”) is a frequent claim in civil litigation where the plaintiff has sustained a head injury. The best evaluation of these claims is performed by a 3-part team of forensic neurologist, neuropsychologist and psychiatrist. The neurologist addresses and structural damage to […]

Addiction and Mental Health

The cannabis landscape changed in 2016 with the passage of Proposition 64 in California, which legalized recreational use of cannabis and possession of less than an ounce, as Prop 215 legalized medicinal use in 1996. Dr. Kan noted that experience has shown that medicinal use of cannabis decreased opioid mortality among patients, dropping by 5% […]

The Problem of Wearing Two Hats: 10 Reasons Why Using the Treating Doctor as a Forensic Psychiatric Expert May Be a Bad Idea

Many attorneys, when working on a case in which the mental health status of one of the parties is a significant issue, consider relying solely on a treating psychiatrist to serve as an independent expert psychiatric witness. Engaging the treating psychiatrist may seem efficient, cost-effective, and simply seeking expertise from the professional who knows the individual […]

David Y. Kan, Md, Dfasam

Substance Use Disorders: It’s a Tough Row to Hoe

This is a slide show presentation and subsequent webinar presented to NARTC by David Kan, M.D., D.F.A.S.A.M., a Diplomate Am. Bd. Psychiatry & Neurology in Psychiatry, Forensic Psychiatry and Addiction Medicine, Associate Clinical Professor Psychiatry, UCSF School of Medicine, an original member of Forensic Psychiatric Associates, LP and current President of the  California Society of Addiction Medicine. Click […]

Mark I Levy Flopped

7 Bullet Points to Remember about PTSD Claims in Litigation

1. Authentic PTSD can, and usually does, produce severe disability of a person’s psychological functioning: It is important to remember that “impairment of psychosocial functioning” is a  sine qua non  for every psychiatric diagnosis listed in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5 ). Thus, although genuine PTSD is usually severely disabling, in the absence of marked […]

Testimony Before the Energy and Commerce Committee Subcommittee on Health

Opioid addiction is taking a devastating toll on our families, friends, and neighbors across the country, but there is hope when patients can access effective treatment services. ASAM is honored today to offer its thoughts and expertise on how we can close the treatment gap, improve the quality of care, and ultimately save lives.

One Force Lacking In Fight Against Opioid Addiction In Rural California: Doctors

fpamed Forensic Psychiatrist and President of the California Society for Addiction Medicine, David Y. Kan, MD DFASAM, was quoted in this recent article published in California Healthline By Pauline Bartolone July 12, 2017 Dr. Mark Satterfield sees a patient in recovery from heroin addiction at the Plumas County public health offices. Local officials say Satterfield […]

A Medical Student-Run Child and Adolescent Psychiatry Clinic: One Institution’s Experience

This report describes a student-run psychiatry clinic with a dual mission of education and service, and the challenges associated with these sometimes competing goals. This clinic serves a vital need within our community and may be an example of the role that student-run clinics can have in fostering interdisciplinary care, psychiatric recruitment, and training for […]

U.S. drug crisis is now pushing up death rates for almost all groups of Americans

The Opioid Crisis Continues to Grow by David Kan MD DFASAM (Distinguished Fellow of the American Society of Addiction Medicine) forensic psychiatrist, fpamed The opioid crisis continues to grow. Recent data from the Centers for Disease Control show that overdose death rates have risen in every ethnic group. The most recent CDC data show that […]

Bright Heart Health

Bright Heart Health’s Medical Director, David Kan, MD, discusses the history of the opioid epidemic, opioid affects on the body, opioid treatment using medication, and more.

David Kan MD Webinar to NARTC on Substance Use Disorders

On January 25, 2017, Forensic Psychiatrist and Substance Abuse Expert, David Kan, MD,DFASAM, the current President-Elect of the California Society of Addiction Medicine, gave a national, interactive webinar to members of the National Association of Railroad Trial Counsel (NARTC) on the subject of Substance Use Disorders, focusing particularly on opioid abuse and its place in […]

Two’s Company, Three’s A Crowd: The Problem of Third Party Presence in Forensic Psychiatric Examinations.

Years ago, the distinguished and esteemed George Washington University forensic psychiatrist Robert I Simon MD, who sadly died earlier this year, wrote a wonderful monograph entitled “Two’s Company, Three’s a Crowd,” outlining the scientific and ethical problems posed by the presence of a third party during a forensic psychiatric examination. In 2003, a California Appellate […]

Staying on Track: Differentiating Between Genuine and False PTSD Claims in Railroad Litigation – Including Both Individual and Mass Tort Cases

These are the slides accompanying a presentation on “PTSD” given by forensic psychiatrist Mark I Levy MD, DLFAPA to the Association of American Railroads Claims Meeting in Nashville, Tennessee on October 12, 2016. Click here to view

Dementia Prevalence in United States Falls Between 2000 to 2012, Report Finds

Psychiatric News Alert The Voice of the American Psychiatric Association and the Psychiatric Community Dementia Prevalence in United States Falls Between 2000 to 2012, Report Finds Between 2000 and 2012, the proportion of U.S. adults 65 and older with dementia decreased significantly, from 11.6% to 8.8%, reported a study published today in JAMA Internal Medicine. […]

fpamed Forensic Psychiatrist Charles Saldanha, MD Assumes New Leadership Position

Charles Saldanha, MD has been appointed Interim Chair of Psychiatry for Alameda Health System. In this role, he will be the physician leader for an integrated public health care system that includes psychiatric emergency, inpatient psychiatry, partial hospitalization, substance use services, ambulatory and inpatient consultation and liaison psychiatry, and mental health services in a skilled […]